Zevra Therapeutics
Advertisement
Zevra Therapeutics, located in Charleston, SC, is focused on advancing the understanding and treatment of idiopathic hypersomnia (IH), a rare neurological sleep disorder characterized by excessive daytime sleepiness. The company is currently enrolling participants in the KP1077D01 clinical trial to evaluate the safety and efficacy of KP1077 capsules, an investigational medication aimed at alleviating the symptoms of IH.
The KP1077D01 study aims to assess various aspects of idiopathic hypersomnia, including excessive daytime sleepiness, sleep inertia, and cognitive impairments commonly referred to as "brain fog." With multiple study sites across the United States, Zevra Therapeutics is committed to improving the lives of those affected by this challenging condition.
Generated from the website
Also at this address
You might also like
Advertisement
